Bugworks Research
Novel antibiotics and immuno-oncology therapies.
Sector
Synthetic biology, therapeutics, diagnostics, agbio, cell therapy, and biological manufacturing.
India's biological capability has long been visible in generics and services. The frontier question is whether that base can move into original therapeutics, platform biology, diagnostics, and biological manufacturing.
This field rewards patience and verification. Strong science, credible trials, and manufacturing discipline matter more than broad platform language.
Novel antibiotics and immuno-oncology therapies.
Cell therapy for retinal diseases.
Precision fermentation platform for enzymes, bio-chemicals, and specialty ingredients.
Cell and gene therapies for cancer care in India.
India's first commercial CAR-T cell therapy, developed from IIT Bombay.
South Asia's largest genomic diagnostics and research platform.
Point-of-care molecular diagnostics platforms.
Thermostable vaccine technology and immunogen design.
Off-the-shelf allogeneic NK cell therapy for affordable cancer immunotherapy.
Biohydrogen from industrial wastewater.
Tissue engineering and regenerative medicine platforms.
Seaweed-based biomass, biostimulants, and bioindustrial products.
AI-assisted diagnostics for microscopy and pathology workflows.
Gas fermentation platform for protein, agriculture, and biomaterials.
Clinical-stage NK cell antibody company targeting hard-to-treat solid tumors.